Name: 苯巴比妥 钠盐
Brand: SIGMA

登录查看公司和协议定价

About This Item

经验公式（希尔记法）:

C₁₂H₁₁N₂NaO₃

CAS Number:

57-30-7

分子量:

254.22

Beilstein:

3802044

EC 号:

200-322-3

MDL编号:

MFCD00036211

UNSPSC代码:

12352202

PubChem化学物质编号:

24898608

NACRES:

NA.77

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

表单

powder

质量水平

200

药品控制

USDEA Schedule IV; Home Office Schedule 3; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

溶解性

H₂O: 1 g/mL
ethanol: 100 mg/mL

创始人

Bayer

SMILES字符串

[Na+].CCC1(C(=O)NC([O-])=NC1=O)c2ccccc2

InChI

1S/C12H12N2O3.Na/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16;/h3-7H,2H2,1H3,(H2,13,14,15,16,17);/q;+1/p-1

InChI key

WRLGYAWRGXKSKG-UHFFFAOYSA-M

正在寻找类似产品? 访问产品对比指南

应用

Phenobarbital sodium salt has been used:

to anesthetize mice for inducing ischemia-reperfusion injury
as a positive control for the activation of constitutive androstane receptor (CAR)
in bioluminescent yeast bioreporters (BLYAS) assay

生化/生理作用

Phenobarbital, a substituted barbituric acid is an antileptic drug and is not easily eliminated from circulation. It hyperpolarizes the synaptic neuronal membranes by favoring the activation of neuronal postsynaptic GABAA receptors by γ aminobutyric acid (GABA). Phenobarbital is also effective in treating neonatal seizures and status epilepticus.

Sedative; hypnotic; anticonvulsant; enhances GABAergic activity.

特点和优势

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Dopamine and Norepinephrine Metabolism and GABAA Receptors pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.